ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

ORI Final Findings Of Scientific Misconduct

September 16, 1994

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Text Of Working Group’s Recommendations

May 19, 1995

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

October 29, 1993

HHS: Gallo Committed Scientific Misconduct In AIDS Virus Discovery

January 8, 1993